This is with reference to Regulation 30(11) of the listing regulations and news articles published in various online & off-line media publications.The company would like to clarify that Dr. Rajib K ...
Mar. 31, 2025 — A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it ... New AI Models Possible ...
Shares of PTC Inc. PTC advanced 1.63% to $155.80 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.13% to 5,638.94 and ...
It does not necessarily reflect the view of The Herald. Garan Croft is set for another homecoming bout as the fourth fight of his professional career will happen in Swansea. On April 19, the Croft ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
PTC News Desk: As militant group Baloch Liberation Army (BLA) continue to hold hostages after hijacking passenger train in Pakistan's Blochistan province, security personnel are conducting a rescue ...
ISTANBUL - Turkiye Garanti Bankasi (IS:GARAN) A.S. (TGBD), also known as Garanti BBVA (BME:BBVA), has submitted a draft issuer ...
Shares of PTC Inc. PTC slipped 2.32% to $157.28 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,572.07 and Dow ...
PTC stock opened at $162.65 on Friday. The stock has a 50-day moving average price of $177.45 and a two-hundred day moving average price of $182.52. PTC has a 12-month low of $155.53 and a 12 ...
It has been about a month since the last earnings report for PTC Inc. (PTC). Shares have lost about 6.4% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
Menkes now is the president of Fare Audit in addition to serving as founder and CEO of PTC. BTN senior editor Donna M. Airoldi spoke with Menkes about his reasons for the purchase, Fare Audit's ...
PTC Therapeutics, Inc. (NASDAQ:PTCT) today reported topline results from the MOVE-FA trial of vatiquinone in patients with Friedreich ataxia. The study did not meet its primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results